Pharma Equity Group A/S
PEG.CO · CPH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | DKK 235 | DKK 480 | DKK 0 | DKK 0 |
| Gross Profit | -DKK 235 | -DKK 480 | DKK 0 | DKK 0 |
| % Margin | – | – | – | – |
| R&D Expenses | DKK 9,002 | DKK 8,820 | DKK 0 | DKK 0 |
| G&A Expenses | DKK 0 | DKK 12 | DKK 1,975 | DKK 1,444 |
| SG&A Expenses | DKK 12,050 | DKK 15,994 | DKK 1,975 | DKK 1,444 |
| Sales & Mktg Exp. | DKK 0 | DKK 15,719 | DKK 0 | DKK 0 |
| Other Operating Expenses | DKK 0 | -DKK 1 | -DKK 5,001 | -DKK 6,349 |
| Operating Expenses | DKK 21,052 | DKK 24,813 | -DKK 3,026 | -DKK 4,905 |
| Operating Income | -DKK 21,287 | -DKK 25,293 | DKK 3,026 | -DKK 1,444 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -DKK 4,950 | -DKK 1,548 | DKK 453 | DKK 6,836 |
| Pre-Tax Income | -DKK 26,237 | -DKK 26,841 | DKK 3,479 | DKK 5,392 |
| Tax Expense | -DKK 1,815 | -DKK 2,232 | DKK 0 | DKK 0 |
| Net Income | -DKK 24,422 | -DKK 24,609 | DKK 3,479 | DKK 5,392 |
| % Margin | – | – | – | – |
| EPS | -0.023 | -0.023 | 0.093 | 0.097 |
| % Growth | -0.4% | -124.4% | -3.8% | – |
| EPS Diluted | -0.023 | -0.023 | 0.078 | 0.097 |
| Weighted Avg Shares Out | 1,068,352 | 1,080,360 | 37,295 | 55,572 |
| Weighted Avg Shares Out Dil | 1,068,352 | 1,080,360 | 44,365 | 55,572 |
| Supplemental Information | – | – | – | – |
| Interest Income | DKK 14 | DKK 14 | DKK 1,449 | DKK 1,151 |
| Interest Expense | DKK 4,964 | DKK 1,562 | DKK 996 | DKK 665 |
| Depreciation & Amortization | DKK 235 | DKK 480 | DKK 1 | DKK 237 |
| EBITDA | -DKK 21,038 | -DKK 24,799 | DKK 4,475 | DKK 6,056 |
| % Margin | – | – | – | – |